Adiponectin, but Not TGF-β1, CTGF, IL-6 or TNF-α, May Be a Potential Anti-Inflammation and Anti-Fibrosis Factor in Keloid

References

• Kim KK, Sheppard D, Chapman HA. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10(4):a022293. doi:10.1101/cshperspect.a022293
   PubMed Web of Science ®Google Scholar
• Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83. doi:10.1016/j.cbi.2018.07.008
   PubMed Web of Science ®Google Scholar
• Jurzak M, Adamczyk K, Antończak P, et al. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro. Acta Pol Pharm. 2014;71(6):972–986.
   PubMed Web of Science ®Google Scholar
• Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606. doi:10.3390/ijms18030606
   PubMed Web of Science ®Google Scholar
• Andrews JP, Marttala J, Macarak E, et al. Keloids: the paradigm of skin fibrosis – pathomechanisms and treatment. Matrix Biol. 2016;51:37–46. doi:10.1016/j.matbio.2016.01.013
   PubMed Web of Science ®Google Scholar
• Ghazizadeh M. The existing data suggest that IL-6 mediated inflammation is a key player and may be considered as a common causative factor for development of keloid. J Nippon Med Sch. 2007;74(1):11–22. doi:10.1272/jnms.74.11
   PubMedGoogle Scholar
• Dong X, Mao S, Wen H. Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation. Biomed Rep. 2013;1(6):833–836. doi:10.3892/br.2013.169
   PubMedGoogle Scholar
• Nguyen JK, Austin E, Huang A, et al. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Arch Dermatol Res. 2020;312(2):81–92. doi:10.1007/s00403-019-01972-3
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim EK, Seo HB, et al. IL-17 induced stromal cell-derived factor-1 and profibrotic factor in keloid-derived skin fibroblasts via the STAT3 pathway. Inflammation. 2020;43(2):664–672. doi:10.1007/s10753-019-01148-1
   PubMed Web of Science ®Google Scholar
• Shi CK, Zhao YP, Ge P, et al. Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway. Eur Rev Med Pharmacol Sci. 2019;23(20):9085–9092. doi:10.26355/eurrev_201910_19311
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res Commun. 2012;425(3):560–564. doi:10.1016/j.bbrc.2012.08.024
   PubMed Web of Science ®Google Scholar
• Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 2015;3(4):243–252. doi:10.1007/s40139-015-0094-y
   PubMedGoogle Scholar
• Luo L, Li J, Liu H, et al. Adiponectin is involved in connective tissue growth factor-induced proliferation, migration and overproduction of the extracellular matrix in keloid fibroblasts. Int J Mol Sci. 2017;18(5):1044. doi:10.3390/ijms18051044
   PubMed Web of Science ®Google Scholar
• Brochu-Gaudreau K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe. Endocrine. 2010;37(1):11–32.
   PubMed Web of Science ®Google Scholar
• Sullivan T, Smith J, Kermode J, et al. Rating the burn scar. J Burn Care Rehabil. 1990;11(3):256–260. doi:10.1097/00004630-199005000-00014
   PubMedGoogle Scholar
• Lodyga M, Hinz B. TGF-β1-A truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2019. doi:10.1016/j.semcdb.2019.12.010
   PubMed Web of Science ®Google Scholar
• Mari W, Alsabri SG, Tabal N, et al. Novel insights on understanding of Keloid scar: article review. J Am Coll Clin Wound Spec. 2015;7(1–3):1–7. doi:10.1016/j.jccw.2016.10.001
   PubMedGoogle Scholar
• Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and Keloids. Int J Mol Sci. 2018;19(3).
   Web of Science ®Google Scholar
• Distler JHW, Györfi AH, Ramanujam M, et al. Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol. 2019;15(12):705–730.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Song SY, Roh H, et al. Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues. Sci Rep. 2018;8(1):8434. doi:10.1038/s41598-018-26501-6
   PubMedGoogle Scholar
• Stewart AG, Thomas B, Koff J. TGF-β: master regulator of inflammation and fibrosis. Respirology. 2018;23(12):1096–1097. doi:10.1111/resp.13415
   PubMed Web of Science ®Google Scholar
• Lipson KE, Wong C, Teng Y, et al. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012;5(1):S24. doi:10.1186/1755-1536-5-S1-S24
   PubMedGoogle Scholar
• Yang H, Huang Y, Chen X, et al. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2), elucidated by treatment with CTGFsiRNA. Acta Ophthalmol. 2010;88(6):652–659. doi:10.1111/j.1755-3768.2009.01641.x
   PubMed Web of Science ®Google Scholar
• Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127(1):98–105. doi:10.1038/sj.jid.5700564
   PubMed Web of Science ®Google Scholar
• Zhu G, Cai J, Zhang J, et al. Abnormal nuclear factor (NF)-kappaB signal pathway and aspirin inhibits tumor necrosis factor alpha-induced NF-kappaB activation in keloid fibroblasts. Dermatol Surg. 2007;33(6):697–708. doi:10.1111/j.1524-4725.2007.33146.x
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100. doi:10.1093/jmcb/mjw011
   PubMed Web of Science ®Google Scholar
• Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–109. doi:10.1016/j.cyto.2016.06.028
   PubMed Web of Science ®Google Scholar
• Yuan B, Huang L, Yan M, et al. Adiponectin downregulates TNF-α expression in degenerated intervertebral discs. Spine. 2018;43(7):E381–E389. doi:10.1097/BRS.0000000000002364
   PubMed Web of Science ®Google Scholar
• Marangoni RG, Masui Y, Fang F, et al. Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. Sci Rep. 2017;7(1):4397. doi:10.1038/s41598-017-04162-1
   PubMed Web of Science ®Google Scholar
• Fang F, Liu L, Yang Y, et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther. 2012;14(5):R229. doi:10.1186/ar4070
   PubMed Web of Science ®Google Scholar